证券研究报告 公用事业|电力 证券分析师 查浩 S1350524060004 zhahao@huayuanstock.com 刘晓宁 S1350523120003 liuxiaoning@huayuanstock.com 蔡思 S1350524070005 caisi@huayuanstock.com 联系人 蔡思 S1350524070005 caisi@huayuanstock.com 市场表现： -20% -15% -10% -5% 0% 5% 相关研究 2024 年 09 月 04 日 三峡能源 (600905.SH ) 增持（维持） ——业绩符合预期，期待绿电价值回归 投资要点： ➢ 事件：2024 年上半年公司实现营业收入 150.6 亿元，同比增长 9.89%，实现归母净利润 40.4 亿元，同比下滑 10.6%，对应 2024 年二季度实现归母净利润 16.2 亿元，同比下滑 22.91%， 符合我们的预期。 ➢ 受利用小时数和电价双重下滑影响，上半年公司利润有所下滑。2024 年上半年公司实现上网 电量 351.1 亿千瓦时，同比增长 28.6%，其中风电/光伏分别实现上网电量 223.3/ ...

证券研究报告 医药生物 证券分析师 刘闯 S1350524030002 liuchuang@huayuanstock.com 市场表现： 康方生物 恒生指数 -19% -6% 8% 21% 34% 47% 23-0823-1023-1123-1224-0124-0224-0324-0424-0524-0624-0724-08 相关研究 1.《康方生物（9926.HK）：打造新 一代 I/O 创新药旗舰，强势出海未来 可期》，2024.07.29 | --- | --- | |-----------------------|----------------------| | 股价数据： 2024 | 年 9 月 3 日 | | 收盘价（港元） | 49.05 | | 年内最高/最低（港元） | 60.00/26.45 | | 总市值（亿港元） | 424.70 | 公司点评 2024 年 9 月 4 日 康方生物 (9926.HK) 买入（维持） ——业绩符合预期，产品销售持续高增，重磅临床加速推进 投资要点： ➢ 公司事件：康方生物发布 2024 年中期业绩公告，产品收入为 9.4 亿元，同比+24%(去年同 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the near term [2]. Core Insights - The company reported a revenue of 34.808 billion yuan for the first half of 2024, a year-on-year increase of 12.38%, and a net profit attributable to shareholders of 11.362 billion yuan, up 27.92%, aligning with expectations [2]. - Improved water inflow and a slight decline in electricity prices are expected to influence the company's performance, with total electricity generation reaching 120.618 billion kWh, a 16.86% increase year-on-year [2]. - Financial expenses decreased more than anticipated, contributing significantly to profit growth, with interest expenses dropping to 5.704 billion yuan, a reduction of 777 million yuan compared to the same period in 2023 [2]. - The report emphasizes the continued attractiveness of hydropower assets, suggesting that the market is re-evaluating the low correlation of hydropower assets, which could lead to a structural bull market for this sector [2]. Summary by Sections Financial Performance - The company achieved a total revenue of 34.808 billion yuan in H1 2024, with a net profit of 11.362 billion yuan, reflecting strong growth [2]. - The financial expenses saw a significant decline, with interest expenses at 5.704 billion yuan, down from the previous year [2]. - Investment income rose to 2.56 billion yuan, marking a 20.55% increase year-on-year [2]. Market Analysis - The report highlights a favorable shift in the discount rate for equity assets, with the implied discount rate for the company decreasing from approximately 10% in 2020 to 7.1% by mid-2024 [2]. - The narrowing of the risk-free rate and credit spread is seen as beneficial for equity assets, particularly in the hydropower sector, which is less affected by macroeconomic fluctuations [2]. Earnings Forecast - The report projects net profits for 2024, 2025, and 2026 to be 33.994 billion yuan, 35.742 billion yuan, and 37.423 billion yuan respectively, with corresponding price-to-earnings ratios of 21, 20, and 19 [4][5].

证券研究报告 医药生物 证券分析师 刘闯 S1350524030002 liuchuang@huayuanstock.com 市场表现： -30% -20% -10% 0% 10% 20% 30% 40% 2023-092023-102023-112023-122024-012024-022024-032024-042024-052024-062024-072024-08 三诺生物 沪深300 相关研究 1.《三诺生物 (300298.SZ)：CGM 海 外发力在即，掘金百亿美元市场》， 2024.04.18 公司点评 2024 年 9 月 4 日 三诺生物（300298.SZ） 买入（维持） ——业绩表现稳健，CGM 潜力可期 投资要点： ➢ 公司事件：三诺生物发布 2024 年中期业绩公告，合并报表口径下 24H1 实现收入 21.3 亿元 （同比+6.26%），归母净利润 2.0 亿元（同比+12.61%），扣非归母 1.8 亿元（同比-10.38%）； 24Q2 实现收入 11.2 亿元（同比-0.53%），归母净利润 1.2 亿元（同比+0.78%），扣非归 母 1.0 亿元（同比-25.42%）。 ...

Investment Rating - The report maintains a "Buy" rating for China Shipbuilding (600150.SH) [3] Core Views - The company achieved a net profit attributable to shareholders of 1.412 billion yuan in the first half of 2024, representing a year-on-year increase of approximately 155.33% [3] - High-value orders are gradually being delivered, accelerating performance realization, with the Clarkson newbuilding index showing a growth of 22.3%, 5.3%, and 10.2% from 2021 to 2023 [3] - The company is expected to deliver a significant portion of its orders from 2021 in 2024, with a higher proportion of high-value ship types being delivered compared to previous years [3][4] - The report forecasts revenue for China Shipbuilding to be 90.89 billion yuan in 2024, with net profit expected to reach 5.112 billion yuan, corresponding to a PE ratio of 33.57 [5] Summary by Sections Financial Performance - In Q2 2024, the company reported a net profit of 1.011 billion yuan, with a non-recurring net profit of 860 million yuan [3] - The company’s revenue for 2024 is projected to be 90.89 billion yuan, with a growth rate of 21.45% [5] - The net profit for 2024 is expected to be 5.112 billion yuan, reflecting a growth rate of 72.86% [5] Market Dynamics - The newbuilding price growth has shifted from market-driven to green renewal demand since Q4 2022, maintaining high order coverage despite a decline in the shipping market [4] - The report indicates that the order backlog extends to 2027-2028, with significant profit realization expected in 2024 [4] Valuation Metrics - The projected PE ratios for 2024, 2025, and 2026 are 33.57, 18.47, and 12.88 respectively, indicating a favorable valuation outlook [5] - The report anticipates a steady increase in return on equity (ROE) from 6.12% in 2024 to 19.40% in 2026 [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][2] Core Views - The company reported a revenue of 14 billion yuan in the first half of 2024, representing a year-on-year growth of 14.42%, and a net profit attributable to shareholders of 1.071 billion yuan, which is an increase of 83.06% year-on-year [1] - The strong performance is attributed to the decline in coal prices and robust electricity demand in Anhui province, with a significant increase in installed capacity and ongoing construction of renewable energy projects [1][2] - The company is expected to benefit from a tight power supply in the province, with projections indicating a power gap exceeding 20 million kilowatts by 2025 [2] Summary by Sections Financial Performance - In Q2 2024, the company achieved a revenue of 7.016 billion yuan, a year-on-year increase of 16.46%, and a net profit of 618 million yuan, up 44.46% year-on-year [1] - The company’s operational capacity as of June 30, 2024, was 12.28 million kilowatts, with an increase of 900,000 kilowatts compared to the end of the previous year [1] Market Dynamics - The electricity demand in Anhui province grew by 13.3% in the first half of 2024, which is expected to drive the company's power generation significantly [1] - The company is strategically positioned to take advantage of the tight supply-demand balance in the electricity market, with expectations of additional revenue from the spot market [2] Future Projections - The company forecasts net profits of 1.886 billion yuan, 2.350 billion yuan, and 2.521 billion yuan for 2024, 2025, and 2026 respectively, with corresponding PE ratios of 10, 8, and 8 [2][4] - The company plans to complete an additional 4 million kilowatts of renewable energy capacity during the 14th Five-Year Plan period, although progress has been slower than anticipated [2]

证券研究报告 海外科技 行业定期报告 证券分析师 郑嘉伟 S1350523120001 zhengjiawei@huayuanstock.com 于炳麟 S1350524060002 yubinglin@huayuanstock.com 联系人 郑冰倩 S1350124050014 zhengbingqian@huayuanstock.com 相关研究 2024 年 09 月 03 日 AI 中报中规中矩，市场预计进入降息首月提防短期波动 ——海外科技周报（24/08/26-24/08/30） 投资要点： ➢ 海外 AI：英伟达 FY2Q25 收入利润再创新高，均超过公司此前业绩指引，但是毛利率开始下滑，收入与 利润同环比增速较上一季度明显下滑。FY25Q2 公司实现 300.4 亿美元营收（yoy+122%，qoq+15%）， GAAP 净利润 166.0 亿美元（yoy+168%，qoq+12%），毛利率为 75.1%，环比下降 3.3pct。根据公 司 3Q25 业绩指引，公司营收指引为 325 亿美元（1±2%），GAAP 口径下毛利率为 74.4%（±50 个基 点），全年毛利率预计在 75%左右， ...

证券研究报告 公用事业|电力 行业定期报告 证券分析师 查浩 S1350524060004 zhahao@huayuanstock.com 刘晓宁 S1350523120003 liuxiaoning@huayuanstock.com 邹佩轩 S1350524070004 zoupeixuan01@huayuanstock.com 戴映炘 S1350524080002 daiyingxin@huayuanstock.com 邓思平 S1350524070003 dengsiping@huayuanstock.com 板块表现： -10% 0% 10% 20% 2023-12-…2024-01-…2024-02-…2024-03-…2024-03-…2024-04-…2024-05-…2024-05-…2024-06-…2024-07-…2024-07-…2024-08-… 沪深300 电力 相关研究 2024 年 09 月 03 日 中长期绿电交易基本规则发布 成都再次限电 看好（维持） ——公用事业 2024 年第 35 周周报（20240831） 投资要点： ➢ 1）低协方差资产组合：长江电力、华能水电、 ...

行业评级：看好（维持） 证券研究报告|行业专题 医药生物 2024年9月3日 | --- | --- | --- | |------------------------------|----------------------------------------|-----------------------------------------------------------------------------------| | | | | | Pharma | 半年报总结：业绩亮眼，盈利拐点信号显著 | | | | | 证券分析师 姓名：刘闯 资格编号： S1350524030002 邮箱： liuchuang@huayuanstock.com | | 请务必阅读报告末页的重要声明 | | 证券分析师 姓名：李强 资格编号： S1350524040001 邮箱： liqiang@huayuanstock.com | 投资要点 ◼ 创新药进入收获阶段，国内商业化+国际化合作推动行业高质量发展：经过近10年的快速发展，中国创新药已进入商业化快速兑现阶段，海外合作/销售 加速，新药研发质量也显著提升，已具备在 ...

证券研究报告 相关研究 交通运输 行业定期报告 投资要点： 证券分析师 孙延 S1350524050003 sunyan01@huayuanstock.com 王惠武 S1350524060001 wanghuiwu@huayuanstock.com 联系人 张付哲 S1350124070010 zhangfuzhe@huayuanstock.com 板块表现： 2024 年 09 月 03 日 看好快递反内卷带动行业价格修复 看好（维持） ——2024 年 8 月 26 日-9 月 1 日交通运输行业周报 一、行业动态跟踪 ➢ 快递物流： 1）快递行业开启反内卷，有望直接带动行业价格修复上涨。7 月 30 日，政治局会议提出 "要强化行业自律，防止"内卷式"恶性竞争"；8 月 22 日，国家邮政局在上海召开规范 市场秩序、提升服务质量专题会议；8 月 23 日，浙江省邮政管理局联合快递业协会召开规 范市场秩序座谈会。在一系列政策带动下，快递行业反内卷有望从反低价竞争入手，考虑 9 月一般为快递行业淡季转旺季时点，当前行业加盟商盈利改善诉求较强，有望快速带动 国内部分价格洼地修复价格，从而改善加盟商盈利状况， ...